Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Options -- Ignore unavailable to you. Want to Upgrade?

To: SecularBull who wrote (3308)	2/21/2000 9:42:00 AM
From: Jill	Read Replies (1) \| Respond to of 8096

I like Girish's AFFX. Here's a stolen part of a post from a 23-year old molecular biologist on that thread: PRODUCT SALES are up 135% on the year and 144% quarter over quarter. That's logarithmic growth. That'll give you orders of magnitude real fast. ie a 135% growth rate gives you a 13 fold growth over 3 years and a 70 fold growth over five. A seventy fold increase over 87 million is 6 billion. I don't really think they'll continue to grow at this rate for five years, but I think growth could continue to accelerate for the next year. Why? 1) The new plant means they can finally cut down on their back orders. 2) As a professional in the molecular biology field, I can tell you that EVERYONE wants access to these chips. It came up at least three times yesterday in a class I'm taking about bioinformatics, every conference I go to has seminars, posteres, talks on gene chips, and look at the numbers: 24 Universities have access. (That's a 60% increase over the last QUARTER, incidentally). Out of how many major research universities worldwide? And how many biotech companies have access? A tiny fraction from the sound of it. All the extra universities and biotechs are going to have to get access if they they want to remain relevant. Then you throw in research institutions and hospitals. Oh yes, we're talking about orders of magnitude. I'm looking at March 250s (still want to sell below support)